We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Lyxor Index Fund-Lyxor Stoxx Europe 600 Pers& Hou Good UCITS ETF | BIT:PHG | Italy | Exchange Traded Fund |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 142.86 | 142.16 | 142.46 | 0 | 08:17:30 |
From Jun 2019 to Jun 2024
Royal Philips Electronics NV (PHIA.AE) said Wednesday it has reached an agreement with US-based GlyGenix Therapeutics Inc to explore the feasability of using ultrasound technologies for gene therapy.
MAIN FACTS:
-The collaboration will research the treatment of Glycogen Storage Disease Type 1a (GSD-1a) in preclinical studies.
-GlyGenix Therapeutics is based in Woodbridge, Connecticut.
-Philips doesn't provide financial details.
- By Amsterdam Bureau, Dow Jones Newswires; amsterdam@dowjones.com
1 Year Lyxor Index Fund-Lyxor S... Chart |
1 Month Lyxor Index Fund-Lyxor S... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
